Novo Nordisk CEO Lars Jorgensen testifies in U.S. Senate hearing on high cost of weight loss drugs, in Washington
- Código: 27854777
- Data do Conteúdo: 24/09/2024
- Inclusão no Site: 24/09/2024 11:32:45
- Assunto: USA-CONGRESS/NOVO
- Legenda: U.S. Sen. Bernie Sanders (I-VT) speaks during Novo Nordisk CEO Lars Jorgensen's hearing before a Senate Health, Education, Labor, and Pensions Committee on U.S. prices for the weight loss drugs Ozempic and Wegovy, on Capitol Hill in Washington, U.S., September 24, 2024. REUTERS/Piroschka van de Wouw ORG XMIT: LIVE
- Serviço/Categoria: Reuters / Reuters Internacional
- Crédito: Reuters/Folhapress
- Dimensão: 47cm x 31cm
- Tamanho: 20.17 megapixels
- Resolução: 300 dpi
- Palavras-chave: N/A